Article title |
Issue |
| |
Abdominal X-rays: Are abdominal X-rays useful in palliative medicine?
|
16.1
|
Adolescence: Palliative care in adolescence
|
2.2
|
Advance directives – the ethical pros and cons
|
10.3
|
Africa: Advancing palliative care research in sub-Saharan Africa: from Venice to Nairobi
|
15.5
|
Africa: Making it real: advances in palliative care in Africa
|
15.1
|
Aging: Aging, pain and palliative care
|
13.3
|
AIDS: Developing palliative care services for patients with AIDS
|
4.4
|
AIDS: Octreotide in treatment of AIDS-related symptoms
|
1.1
|
AIDS: The changing face of terminal care for AIDS
|
9.6
|
AIDS: The management of AIDS dementia complex
|
5.4
|
Akathisia: Acute akathisia in palliative care
|
12.1
|
Albania: The development of terminal care in Albania
|
8.6
|
Anaemia and blood transfusions in palliative care
|
10.2
|
Anaemia: The management of anaemia
|
6.5
|
Analgesia: A new 24-hour morphine hydrogel suppository
|
7.5
|
Analgesia: A new treatment option for chronic cancer pain
|
1.1
|
Analgesia: An overview of opioids in palliative care: part 1
|
13.6
|
Analgesia: Analgesic blocks in palliative care
|
2.3
|
Analgesia: Analgesic use in patients with renal failure
|
7.6
|
Analgesia: Assessment and treatment of pain in children in palliative care
|
1.1
|
Analgesia: Cannabis and pain control
|
11.6
|
Analgesia: Conversion formula for transdermal fentanyl
|
5.3
|
Analgesia: End-of-life patient-controlled analgesia at home
|
12.1
|
Analgesia: Gabapentin as an analgesic
|
8.2
|
Analgesia: International control of opioids for medical use
|
4.6
|
Analgesia: Intraspinal opioids and local anaesthetics for cancer pain
|
1.4
|
Analgesia: Is corticosteroid prescribing appropriate in palliative care?
|
13.5
|
Analgesia: Is the WHO analgesic ladder active or archaic?
|
15.4
|
Analgesia: Latin American survey on the treatment of cancer pain
|
13.6
|
Analgesia: Managing phantom limb pain
|
13.2
|
Analgesia: Methadone: an alternative conversion regime
|
9.3
|
Analgesia: Methadone: the analgesic
|
12.5
|
Analgesia: Modified-release opioids
|
8.4
|
Analgesia: Morphine – doctors’ beliefs and the myths
|
7.5
|
Analgesia: Neurolytic coeliac plexus block in the treatment of abdominal cancer pain
|
11.4
|
Analgesia: Neurotoxic effects of opioids
|
3.4
|
Analgesia: NSAIDs: are they effective in treating cancer pain?
|
11.1
|
Analgesia: Opioid analgesia: new insights
|
13.5
|
Analgesia: Opioids and the control of breathing: what do we know?
|
13.2
|
Analgesia: Oral ketamine in patients with difficult cancer pain
|
12.2
|
Analgesia: Oral transmucosal fentanyl citrate for the management of breakthrough pain
|
8.1
|
Analgesia: Oxycodone: a review of the literature
|
8.3
|
Analgesia: Pain therapy in Pancoast’s syndrome
|
2.4
|
Analgesia: Patient-controlled analgesia in cancer pain
|
3.3
|
Analgesia: Rapid opioid titration in severe cancer pain
|
12.1
|
Analgesia: Recommendations for the use of non-analgesic drugs in palliative care
|
10.6
|
Analgesia: Sustained-release morphine sulphate in cancer pain
|
9.4
|
Analgesia: Syringe drivers and subcutaneous sites: a review
|
13.4
|
Analgesia: The modern history of morphine use in cancer pain
|
12.4
|
Analgesia: The physiology of somatostatin and its synthetic analogue, octreotide
|
1.1
|
Analgesia: The role of anticonvulsants in palliative care
|
4.1
|
Analgesia: The role of ketamine in pain control
|
3.4
|
Analgesia: The role of nebulised drugs in palliating respiratory symptoms of malignant disease
|
2.1
|
Analgesia: The treatment of morphine-induced constipation
|
5.1
|
Analgesia: The use of antitussive drugs in terminally ill patients
|
11.6
|
Analgesia: The use of implantable pumps in palliative care
|
13.2
|
Analgesia: The use of levomepromazine in palliative care
|
12.1
|
Analgesia: The use of methadone in the care of the dying
|
4.5
|
Analgesia: The use of NSAIDs in patients with cancer: just how safe is it?
|
8.5
|
Analgesia: Tramadol – a step towards the ideal analgesic?
|
2.2
|
Analgesia: Tramadol and cancer pain
|
9.2
|
Analgesia: Transdermal opioid control of cancer pain
|
3.4
|
Analgesia: Treatment of bone pain with bisphosphonates
|
1.4
|
Analgesia: WHO analgesic ladder – or lift?
|
10.3
|
Anorexia: Treating cancer patients with anorexia-cachexia syndrome
|
14.5
|
Anorexia: Treating the anorexia of cancer
|
5.6
|
Antibiotics: Antibiotic choices in palliative care
|
4.1
|
Antibiotics: Antibiotics and palliative care
|
13.1
|
Antibiotics: How effective are parenteral antibiotics in hospice patients?
|
15.3
|
Architecture: Palliative care and architecture: from hospital to people
|
5.4
|
Art therapy: The value of art therapy – case studies from France
|
16.1
|
Art: Understanding children’s pain through drawings
|
7.6
|
Arts: All-consuming pain
|
8.6
|
Arts: An innovative, practical course in the medical humanities
|
8.5
|
Arts: Ars moriendi: images of death in Spanish art
|
4.5
|
Arts: Bringing the arts to the bedside
|
11.6
|
Arts: Creativity and coming of age
|
7.4
|
Arts: Empathy, creativity and the arts in palliative care
|
6.3
|
Arts: Providing scope for creative growth in palliative care
|
8.4
|
Arts: Teaching through artwork in terminal care
|
9.1
|
Ascites: A review of the management of malignant ascites
|
12.2
|
Ascites: Controlling malignant ascites
|
8.5
|
Aspiration, pleural: Improving aspiration technique
|
8.2
|
Assessment tools: Examining the comfort of the unconscious patient
|
9.6
|
Assessment tools: Methods for assessing physical functioning in cancer patients
|
15.4
|
Assessment tools: Monitoring a hospital palliative care team using the PACA tool
|
13.2
|
Assessment tools: Symptom assessment in terminally ill cancer patients
|
15.2
|
Assessment: Patient self-assessment or carer assessment: are these the only options?
|
7.1
|
Attitudes to death: Mortality, metaphors and the media
|
7.6
|
Attitudes to death: Now and at the hour of our death: the Ars moriendi and modern dying
|
8.5
|
Audit of deaths: Ensuring that patients are able to die a good death
|
11.4
|
Audit: Access to specialist palliative care for cancer patients
|
13.2
|
Audit: Auditing palliative care in general practice
|
3.3
|
Audit: Monitoring quality in an acute hospital-based palliative care service in Singapore
|
15.5
|
Audit: Organisational audit for specialist palliative care services
|
1.4
|
Auditory hallucinations: How common are auditory hallucinations in palliative care?
|
11.3
|
| |
Behavioural problems in palliative care patients
|
11.2
|
Belgium: Palliative care associations – the Belgian experience
|
10.6
|
Belgium: Palliative day care in Belgium: first observations
|
12.4
|
Belgium: Specialist palliative care training in Belgium
|
6.4
|
Benefits: An audit of welfare benefits advocacy services in a hospice
|
13.1
|
Bereavement – a social phenomenon?
|
8.6
|
Bereavement in the classroom
|
11.1
|
Bereavement visiting in the community
|
12.2
|
Bereavement: A metal strongbox – a metaphor for use in bereavement work
|
8.1
|
Bereavement: A skills course for volunteer bereavement counsellors
|
15.3
|
Bereavement: Bereaved children’s support groups: where are we now?
|
7.4
|
Bereavement: Children and bereavement – what are the issues?
|
1.1
|
Bereavement: Death, bereavement and stepfamilies
|
11.5
|
Bereavement: Developing a multi-agency bereavement service
|
9.4
|
Bereavement: Grief in children
|
2.2
|
Bereavement: Group work with bereaved children
|
1.3
|
Bereavement: Helping children work through their grief
|
3.2
|
Bereavement: Hospice-based groups for bereaved siblings
|
3.1
|
Bereavement: Involving volunteers in bereavement counselling
|
5.2
|
Bereavement: Loss and palliative care
|
14.1
|
Bereavement: Saying goodbye
|
2.1
|
Bereavement: Supporting bereaved people with intellectual disabilities
|
12.6
|
Bereavement: Symbolic death as grief therapy
|
3.1
|
Bereavement: Symbolic death as grief therapy: Part II
|
3.2
|
Bereavement: Teaching children to understand death and grieving
|
9.6
|
Bereavement: Teamwork with families facing bereavement
|
1.4
|
Bereavement: The case study masterclass: Case 14. A complex bereavement after the death of a patient with learning difficulties
|
11.2
|
Bereavement: The provision of grief services by primary care physicians
|
13.4
|
Bereavement: The role of bereavement counselling in hospice work
|
7.1
|
Bereavement: UK bereavement services for children and young people
|
12.5
|
Bereavement: Working with children facing bereavement as individuals
|
1.2
|
Bisphosphonates: The use of bisphosphonates in palliative care
|
7.2
|
Body image: Body image and the impact of terminal disease
|
4.5
|
Bone metastases: Imaging of skeletal metastases
|
6.3
|
Bone metastases: The diagnosis and treatment of bone metastases
|
14.2
|
Book review: Being old is different: person-centred care for old people
|
15.5
|
Book review: Death and dying: a sociological introduction
|
14.6
|
Book review: Euthanasia and law in Europe
|
15.6
|
Book review: Palliative Care Formulary Third Edition
|
16.3
|
Book review: The common sense guide to improving palliative care
|
15.4
|
Bowel obstruction: Malignant bowel obstruction
|
8.4
|
Bowel obstruction: Malignant bowel obstruction in advanced and terminal cancer patients
|
1.1
|
Brain tumour: The case study masterclass: Case 28. Another challenging patient with a primary brain tumour
|
13.5
|
Brain tumours: Convulsive seizures in patients with brain tumours
|
14.1
|
Brain tumours: Malignant brain tumours and palliative care
|
9.1
|
Brain tumours: Specialist occupational therapy for patients with brain tumour
|
16.2
|
Brain tumours: The case study masterclass: Case 8. Is palliative care always helpful?
|
10.2
|
Breakthrough Cancer Pain (BTcP) Treatment: Challenges and New Solutions in Breakthrough Cancer Pain (BTcP) Treatment
|
16.3:Sponsoredsupplement
|
Breakthrough pain: Challenges in the management of breakthrough pain
|
8.6:Sponsoredsupplement
|
Breakthrough pain: Current thinking in the management of cancer breakthrough pain
|
12.5:Sponsoredsupplement
|
Breakthrough pain: Realising unmet needs in breakthrough pain
|
14.1
|
Breakthrough pain: The management of breakthrough cancer pain: is current practice best practice?
|
13.1
|
Burn-out: Suffering – a problem that also affects nurses
|
10.2
|
Burnout – what is at stake?
|
2.1
|
Burnout: Recent research into staff stress in palliative care
|
4.3
|
| |
Cambodia: A palliative care unit for AIDS and cancer sufferers in Cambodia
|
13.6
|
Canada: Palliative care in Canada
|
5.4
|
Canada: The evolution of palliative medicine education in Canada
|
6.6
|
Cancer: Paracetamol allergy in a patient with advanced cancer
|
15.1
|
Cancer: Prognosis in patients with advanced incurable cancer
|
14.4
|
Cancer: The cancer care triangle
|
11.3
|
Carcinoma: The case study masterclass: Case 1. Carcinoma of the gastric fundus
|
9.1
|
Cardiac failure: Breathlessness and fatigue in cardiac failure
|
11.1
|
Care homes: Raising standards for elderly people dying in care homes
|
14.6
|
Care homes: Supporting palliative care in care homes – the way forward?
|
12.2
|
Care pathway: Developing an integrated care pathway for the dying patient
|
4.6
|
Caring: Keeping the balance
|
9.1
|
Caring: Taking care
|
7.1
|
Cerebral metastases: The management of cerebral metastases
|
5.1
|
Chemotherapy: The case study masterclass: Case 30. And baby came too: Lucy’s story
|
14.1
|
Chemotherapy: the palliative role
|
5.5
|
Chile: Palliative care in Chile
|
4.4
|
Cicely Saunders – a voice for the voiceless
|
12.5
|
Cicely Saunders: A weekend at St Christopher’s
|
1.2
|
Clinical supervision can benefit palliative care
|
15.4
|
Colombia: Why dying at home indicates unmet needs in Colombia
|
15.3
|
Colon: The case study masterclass:. Case 2. Adenocarcinoma of the sigmoid colon
|
9.2
|
Comment: A chance for end-of-life care to become mainstream
|
15.6
|
Comment: A long and winding road
|
14.6
|
Comment: Bringing palliative care on to the European agenda
|
16.2
|
Comment: Equity of access
|
15.1
|
Comment: It is our responsibility to promote care, not killing
|
16.3
|
Comment: Losing the label of elitism
|
14.4
|
Comment: Love and loss: a timely tribute
|
14.5
|
Comment: Meeting the challenge of palliation beyond cancer
|
15.5
|
Comment: New year, new direction?
|
14.2
|
Comment: Palliative care is no longer the Cinderella specialty
|
16.1
|
Comment: Respecting culture near the end of life
|
15.2
|
Comment: Who’s afraid of palliative care?
|
15.3
|
Communication – what works?, Family information and
|
12.6
|
Communication: Answering difficult questions
|
12.1
|
Communication: Bedside manner revisited: teaching effective interaction
|
1.2
|
Communication: Breaking bad news and the challenge of communication
|
4.2
|
Communication: Communicating palliative care through images
|
12.2
|
Communication: Hotline for palliative care
|
10.6
|
Communication: Language and speech
|
9.6
|
Communication: Overcoming language barriers in palliative care
|
14.2
|
Communication: Palliative care: only a phone call away
|
9.3
|
Communication: Sharing knowledge on the web: the Spanish experience
|
14.6
|
Communication: Speaking without words
|
6.3
|
Communication: The contribution of speech and language therapy to palliative care
|
6.4
|
Communication: The link between palliative and supportive care
|
13.5
|
Communication: Turning to palliative care
|
12.3
|
Communication: Video communication and palliative care at home
|
4.5
|
Communication: Videoconferencing and palliative care
|
7.5
|
Community care: Palliative care in general practice – a new initiative
|
1.1
|
Community hospital beds: What relevance do community hospital beds have for palliative care patients?
|
9.4
|
Community palliative care: The Gold Standards Framework in Community Palliative Care
|
10.3
|
Complementary medicine can benefit palliative care – part 1
|
15.5
|
Complementary medicine can benefit palliative care – part 2
|
15.6
|
Complementary therapy: Acupuncture in palliative care
|
7.2
|
Complementary therapy: Alternatives and complements
|
8.2
|
Complementary therapy: Art therapy and practice in palliative care
|
2.3
|
Complementary therapy: Art therapy and symptom control: a team approach
|
13.3
|
Complementary therapy: Ayurveda and palliative care
|
8.3
|
Complementary therapy: Caring clowning as a healing art in palliative care
|
10.5
|
Complementary therapy: Catharsis in palliative care
|
4.4
|
Complementary therapy: Cognitive behavioural therapy in the palliative care setting
|
12.4
|
Complementary therapy: Complementary medicine for patients with cancer
|
5.3
|
Complementary therapy: Complementary therapies in palliative care
|
3.4
|
Complementary therapy: Dance and movement therapy
|
6.2
|
Complementary therapy: Developing a cognitive behaviour therapy service
|
13.5
|
Complementary therapy: Do companion animals have therapeutic value?
|
8.2
|
Complementary therapy: Group music therapy for young bereaved teenagers
|
7.6
|
Complementary therapy: Learning to rest when in pain
|
9.2
|
Complementary therapy: Life review in palliative care
|
11.6
|
Complementary therapy: Mind–body therapies and the psycho-oncology debate
|
10.1
|
Complementary therapy: Palliative care and the need for a metaphysical approach
|
4.4
|
Complementary therapy: Psychodynamic counselling in specialist palliative care
|
4.3
|
Complementary therapy: Psychosocial support and therapy in cancer care
|
1.3
|
Complementary therapy: The supportive role of music
|
2.2
|
Complementary therapy: The use of touch in palliative care
|
3.3
|
Concordance: To take or not to take:
|
10.1
|
Consent: The implications of informed consent in palliative care
|
4.1
|
Continuity of care: Palliative medicine for all
|
8.6
|
COPD: A palliative approach for COPD and heart failure?
|
8.6
|
COPD: End-stage respiratory failure
|
10.3
|
Corticosteroids in palliative care
|
5.2
|
Corticosteroids: Management of the adverse effects of corticosteroids
|
11.2
|
Cost of care: Evidence-based medicine and the costs of palliative care
|
15.5
|
Cost of care: The effect of treatment choices on the total cost of palliative care
|
6.3
|
Counselling: Psychological needs and care in the hospice setting
|
2.3
|
Cremation: Modernity, Britain and the culture of cremation
|
7.4
|
Creutzfeldt-Jakob disease (CJD): An overview of the care issues for Creutzfeldt-Jakob disease
|
10.1
|
Creutzfeldt-Jakob disease (CJD): Nursing patients with variant Creutzfeldt-Jakob disease
|
10.1
|
Croatia: Palliative care in Croatia – an international collaboration
|
12.3
|
Cultural issues: Death, dying and burial rites in Islam
|
14.4
|
Cultural issues: End-of-life care for Muslims and Christians in Lebanon
|
15.1
|
Cultural issues: The case study masterclass: Case 32. Complex end-of-life care: cultural issues
|
14.3
|
Cystic fibrosis: Adults with cystic fibrosis
|
5.4
|
Cystic fibrosis: Can we provide effective palliative care for adults with cystic fibrosis?
|
9.4
|
Cystic fibrosis: The case study masterclass: Case 24. Managing a young woman with cystic fibrosis
|
13.1
|
| |
Day care: Hospice day care
|
9.4
|
Day care: Promoting self-worth in the terminally ill
|
3.2
|
Day care: The case study masterclass: Case 29. Psychological care in palliative day care
|
13.6
|
Day care: What does palliative day care mean to you?
|
13.4
|
Day hospices: A review of the literature on hospice or palliative day care
|
12.5
|
Day hospices: The changing face of the day hospice
|
8.4
|
Day hospices: What do doctors actually do in the day hospice?
|
11.3
|
Death plans: Do-it-yourself funerals and The Natural Death Centre
|
8.2
|
Death plans: Facing death with confidence
|
9.3
|
Death rituals: Being present at the last moments of life
|
5.6
|
Death rituals: Between the living and the dead
|
8.4
|
Death rituals: Supporting the dying in myth and reality
|
3.2
|
Death: A philosophical consideration of attitudes towards death
|
12.5
|
Death: A room for dying in: patient’s need or nurse’s fantasy?
|
10.4
|
Death: Perceptions of existential experiences of death and dying
|
11.5
|
Death: Raising public awareness about planning a funeral
|
16.2
|
Death: Reflections on a ‘good death’ in palliative care
|
11.6
|
Death: The crisis of dying
|
2.1
|
Dehydration: Artificial hydration and nutrition at the end of life
|
7.6
|
Delirium in palliative medicine
|
2.2
|
Delirium in terminal illness
|
12.5
|
Delirium: Risk factors predicting the development of delirium
|
11.6
|
Delirium: The management of delirium in hospice practice
|
4.4
|
Dementia: Can palliative care improve the symptoms during the terminal phase of dementia?
|
11.3
|
Dementia: The case study masterclass. Case 16. A patient with rapidly progressive dementia
|
11.4
|
Denial, Working with the patient who is in
|
12.6
|
Dental care: The need for dental involvement in palliative care
|
13.3
|
Depression: Diagnosing and treating depression in the terminally ill
|
5.5
|
Depression: Diagnosis and treatment of depression in palliative care
|
9.5
|
Depression: The assessment and management of depression in the terminally ill
|
12.3
|
Depression: The assessment of depression in palliative care patients
|
6.5
|
Depression: The use of psychostimulants in terminally ill patients
|
8.6
|
Dermatitis: Irritant contact dermatitis and stomas in palliative care
|
14.2
|
Dermatology: A case of life-threatening dermatological emergency
|
15.4
|
Dermatology: Cutaneous paraneoplastic syndromes – Part 1
|
6.3
|
Dermatology: Cutaneous paraneoplastic syndromes – Part 2
|
6.4
|
Developments in palliative care: The next ten years
|
10.1
|
Diabetes: Practical management of diabetes mellitus
|
13.6
|
Diabetes: Treating diabetes mellitus in palliative care patients
|
10.5
|
Dignity: An exploration of the meaning of dignity in palliative care
|
5.6
|
Disabilities: Improving care for patients with intellectual disabilities
|
16.2
|
Disclosure: Does truth-telling influence patients’ psychological distress?
|
12.3
|
Disclosure: To tell or not to tell
|
9.5
|
Drooling: The use of botulinum toxin A to treat drooling in children
|
14.6
|
Drooling: Treatment of drooling
|
7.1
|
Drugs: The 20 essential drugs in palliative care
|
6.4
|
Dysphagia in advanced non-head and neck malignancy, Oropharyngeal
|
12.6
|
Dyspnoea and cough
|
7.5
|
Dyspnoea: Dyspnoea in cancer patients
|
13.4
|
| |
EAPC Task Force on Family Carers: aims and objectives
|
16.2
|
EAPC task force on the development of palliative care in Europe: autumn 2004
|
11.6
|
EAPC: 10th Congress of the European Association for Palliative Care
|
14.5
|
EAPC: 6th Congress of the EAPC: 22–24 September 1999
|
6.1
|
EAPC: An overview of the Lyon Congress
|
9.5
|
EAPC: An update on the Budapest Commitments
|
16.1
|
EAPC: Beyond the borders
|
12.2
|
EAPC: Beyond the borders – where do we go?
|
12.1
|
EAPC: Caution – risk of learning! A report from Trondheim
|
15.4
|
EAPC: Certainties and questions
|
10.3
|
EAPC: European views on palliative care
|
2.3
|
EAPC: Latest report from the EAPC Task Force on the Development of Palliative Care in Europe
|
13.4
|
EAPC: Lost in translation?
|
13.5
|
EAPC: One voice – one vision
|
10.2
|
EAPC: Palliative care development: a challenge for the future
|
14.3
|
EAPC: Risk of learning?
|
12.3
|
EAPC: Taking up the EAPC challenge
|
12.4
|
EAPC: The 7th EAPC Congress in the heart of Palermo
|
7.6
|
EAPC: The challenge of palliative care
|
9.3
|
EAPC: The development of the European Association for Palliative Care
|
4.5
|
EAPC: The EAPC Geneva conference revisited
|
7.2
|
EAPC: The EAPC: new developments for the new millennium
|
8.1
|
EAPC: The history and development of the EAPC: Part II
|
4.6
|
EAPC: Trends in palliative care in Europe – concepts and tools - Proceedings of a scientific symposium on the occasion of the 7th Congress of the European Association for Palliative Care (EAPC) 1–5 April 2001, Palermo, Sicily
|
10.1:Sponsoredsupplement
|
Eastern Europe: Beacons in Eastern Europe
|
9.5
|
Eastern Europe: The Poznan Declaration 1998
|
6.2
|
Education and training: Assessing training needs to extend the scope of palliative care
|
8.1
|
Education and training: Between personal aspirations and professional skills
|
9.3
|
Education and training: Bridging the gap: European collaboration in palliative care education
|
10.6
|
Education and training: Educating the young
|
11.1
|
Education and training: Intercultural experiences of training in the Maghreb
|
12.1
|
Education and training: Palliative nurse education – towards a common language
|
11.4
|
Education and training: The educational needs of lay carers
|
5.6
|
Education and training: The goldfish bowl
|
11.2
|
Education and training: Training in palliative care
|
9.4
|
Education and training: Training of care home staff
|
10.4
|
Education: Education and training in palliative medicine in European Community member states
|
1.1
|
Education: Establishing an education programme in terminal care
|
14.1
|
Education: On the learning curve at Trinity Hospice
|
2.2
|
Education: Online courses for nurses working in palliative care
|
16.2
|
Education: Skill and attributes of doctors in palliative medicine: a study
|
2.4
|
Education: The International School for Cancer Care
|
3.1
|
Educational training: Teaching palliative care: a blended approach
|
14.4
|
Elderly care: Palliative care for older people
|
14.4
|
End-of-life care: Is palliative care synonymous with end-of-life care?
|
10.6
|
End-of-life care: Making sense of end-of-life distress
|
15.1
|
End-of-life care: The national end-of-life care strategy: a summary
|
16.1
|
Endocrine therapy in advanced malignancy
|
2.4
|
Equality: Anti-discrimination, emotions and professional practice
|
5.4
|
Error management in palliative care
|
10.3
|
Ethics and the transversality of hospital palliative care teams
|
6.2
|
Ethics for all – from enthusiasm to standards
|
6.2
|
Ethics: A question of ethics
|
10.4
|
Ethics: A review of the doctrine of double effect
|
5.4
|
Ethics: Did doctors defy Pope John Paul II’s wishes on treatment?
|
14.5
|
Ethics: Ethical decision-making in palliative care
|
4.4
|
Ethics: Ethical problems in nursing the terminally ill
|
2.4
|
Ethics: Ethical questions at the end of life
|
10.1
|
Ethics: Hospital ethics committees: a historical perspective and a modern Turkish example
|
14.6
|
Ethics: Palliative care and the principles of biomedical ethics
|
10.4
|
Ethics: Palliative care in Europe: towards a more comprehensive understanding
|
8.1
|
Ethics: Patients deciding to forgo or stop active treatment for cancer
|
12.3
|
Ethics: Science is the modern religion and we are its ministers
|
5.6
|
Ethics: Sedation and ethical contradiction
|
3.1
|
Ethics: The Calicut Declaration
|
5.3
|
Ethics: The case study masterclass: Case 39 answers. Facing an ethical dilemma
|
15.5
|
Ethics: The case study masterclass: Case 39. Facing an ethical dilemma in a patient with head and neck cancer
|
15.4
|
Ethics: The ethical approach to the caress at the end of life
|
12.4
|
Ethics: When the family demands the discontinuation of morphine
|
7.4
|
Ethnic minorities: Culture and ethnicity
|
6.2
|
Ethnic minorities: Palliative care for minority ethnic groups
|
11.1
|
Ethnic minority: Opening doors
|
2.1
|
Europe: Do we need Europe in everyday palliative care?
|
12.5
|
Europe: IIMPaCCT: standards for paediatric palliative care in Europe
|
14.3
|
Europe: Palliative care in Europe: experiences and the future
|
15.4
|
Euthanasia – a European debate
|
7.4
|
Euthanasia – good medical practice or murder?
|
6.4
|
Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force
|
10.2
|
Euthanasia: another view
|
1.4
|
Euthanasia: Attitudes of healthcare professionals towards euthanasia
|
1.3
|
Euthanasia: Conclusions on euthanasia
|
1.3
|
Euthanasia: Decisions on life and death
|
1.2
|
Euthanasia: Legal matters concerning euthanasia at European level
|
12.2
|
Euthanasia: Palliative care and the euthanasia debate in Australia
|
5.1
|
Euthanasia: Regarding euthanasia
|
1.1
|
Euthanasia: Request for euthanasia: time to ask, time to listen
|
7.5
|
Euthanasia: Research on attitudes towards euthanasia in terminally ill patients
|
10.2
|
Euthanasia: Should euthanasia be an option in palliative care?
|
6.4
|
Euthanasia: The EAPC Ethics Task Force on Palliative Care and Euthanasia
|
13.2
|
Euthanasia: The myth of mercy killing
|
8.4
|
Euthanasia: Why I oppose euthanasia in exceptional circumstances
|
7.4
|
Evidence-based care: Evidence-based palliative care?
|
6.6
|
Evidence-based care: Need for increased evidence in palliative care
|
7.5
|
Evidence-based care: Scott’s Parabola applied to palliative care
|
11.3
|
Evidence-based care: The need for evidence-based proof in palliative care
|
9.3
|
| |
Family care – new principles
|
2.1
|
Family care: Family meetings as a means of support for patients
|
14.3
|
Fatigue: Cancer-related fatigue during the cancer journey
|
14.3
|
Fatigue: The management of cancer-related fatigue
|
11.1
|
Fatigue: The treatment of fatigue in palliative care patients
|
10.6
|
Feeding tubes in palliative care
|
9.6
|
France: Putting the plans for French palliative care into action
|
10.1
|
France: SFAP: France is witnessing major developments in palliative care
|
16.2
|
Fungating wounds: Palliative management of fungating wounds
|
10.3
|
Fungating wounds: The case study masterclass: Case 5. Fungating carcinoma of the breast
|
9.5
|
Fungating wounds: The management of malignant wounds
|
7.4
|
| |
Genetics: A focus on hereditary diseases
|
8.4
|
Genetics: Investigating genetic predisposition to cancer
|
7.5
|
Genetics: The case study masterclass: Case 34. Referring a patient with terminal
|
14.5
|
Geriatrics: End-of-life care for older people
|
10.4
|
Geriatrics: Special care for elderly patients
|
5.5
|
Germany: Diversity in palliative care between the UK and Germany
|
15.1
|
Germany: Nurse-led home care services for children in Germany
|
12.2
|
Germany: Palliative care in Germany – 14 years on
|
5.2
|
Greece: Development of a care programme for older people
|
13.5
|
Greece: Promoting palliative care in Greece
|
5.3
|
Guidelines: Palliative Cancer Care Guidelines in Scotland
|
1.3
|
Guidelines: The Scottish Guidelines
|
1.3
|
Gynaecological malignancy: Complications of radiotherapy for gynaecological malignancy
|
5.6
|
| |
Haematology: The quality of terminal care in haematology
|
2.4
|
Haemoptysis: Treatment of haemoptysis in palliative care patients
|
10.4
|
Heart failure and palliative care
|
8.1
|
Heart failure: A palliative care approach for patients with heart failure
|
13.5
|
Hiccups: The treatment of hiccups in terminal patients
|
10.5
|
History of palliative medicine: Care of the dying in 18th century Spain – the non-hospice tradition
|
6.1
|
History of palliative medicine: European palliative care in the longue durée
|
8.3
|
History of palliative medicine: Palliative care history: a ritual process?
|
7.2
|
History of palliative medicine: St Joseph’s Hospice: then
|
8.3
|
History of palliative medicine: Tuberculosis, poverty and the first ‘hospices’ in Ireland
|
10.4
|
Home care: Continuing care in a university hospital setting
|
2.3
|
Home care: Cross-border care for oncology patients
|
4.1
|
Home care: Living alone and dying at home: a realistic alternative?
|
13.6
|
Home care: Palliative care at home in cancer patients in Milan
|
16.1
|
Home care: The benefits of home care for the terminally ill
|
4.3
|
Homeopathic approach to symptom control, Researching the
|
10.6
|
Hong Kong: Palliative care in Hong Kong
|
4.6
|
Hope: The role of hope in serious illness and dying
|
12.1
|
Hospice management – translating the vision
|
6.6
|
Hospice: The hospice of the future Part II
|
1.4
|
Hospice: Transferring patients from hospices to nursing homes
|
13.6
|
Hospices: Hospice gardens
|
6.1
|
Hospices: The hospice of the future
|
1.3
|
Hospices: The need for adjustable lighting in palliative care
|
4.3
|
Hospices: The UK Forum for Hospice and Palliative Care Services Overseas
|
9.2
|
Hospital palliative care team: Rituals of the hospital palliative care team
|
9.6
|
Hospital palliative care teams: Difficulties faced by hospital palliative care teams
|
6.1
|
Hungary: The development of terminal care in Budapest, Hungary
|
9.6
|
Hydration: Artificial hydration (AH) for people who are terminally ill
|
4.4
|
Hypercalcaemia: Bisphosphonate infusions for hypercalcaemia of malignancy
|
15.5
|
Hypercalcaemia: Management of cancer-associated hypercalcaemia
|
1.4
|
Hypercalcaemia: Pathophysiology of osteolysis: the putative mode of action of bisphosphonates
|
1.3
|
Hypercalcaemia: The case study masterclass: Case 27. A patient with refractory hypercalcaemia
|
13.4
|
Hypercalcaemia: Tumour-induced hypercalcaemia
|
9.1
|
Hypnosis: Clinical hypnosis in palliative care
|
3.2
|
Hypnosis: principles of use and benefits in palliative care
|
13.3
|
Hypnosis: Using hypnosis in palliative care: a clinician’s experience
|
16.2
|
Hypodermoclysis in palliative care, The use of
|
12.6
|
| |
India: Palliative care in the developing world: a social experiment in India
|
13.2
|
India: Promoting effective palliative care in India
|
3.3
|
Infection control in hospices
|
10.2
|
Infection control: Palliative care in infectious diseases
|
1.2
|
Information (for patients): Final choices – the necessity for information
|
6.5
|
Information (for patients): Information needs of patients and families
|
9.3
|
Information (for patients): Information provision for palliative care families
|
11.4
|
Information needs: How are the carers being cared for? A review of the literature
|
15.4
|
Information needs: Information on palliative care from the family’s perspective
|
14.3
|
Information needs: Suffering and the end of life
|
9.1
|
Information technology in practice
|
6.1
|
Information technology: Implementing a patient administration system
|
7.1
|
Information technology: Navigating new information technologies
|
5.5
|
Innovations in palliative care: New horizons
|
9.4
|
Insomnia and sleep disturbances
|
9.1
|
Intensive care: The case study masterclass: Case 43 answers. Fulfilling a patient’s wish to go home from intensive care
|
16.3
|
Intensive care: The case study masterclass: Case 43. Fulfilling a patient’s wish to go home from intensive care
|
16.2
|
Intensive care: The relationship between palliative and intensive care
|
10.5
|
Intimacy: Intimate distance
|
5.2
|
Ireland: Has Ireland’s national policy benefited palliative care?
|
15.2
|
Ireland: Ireland attempts to change culture for care of the dying
|
14.6
|
Israel breaks new ground with law for the terminally ill
|
14.4
|
Italy: Palliative care in Italy in the new millennium
|
8.2
|
Italy: The National Health Service and the care for the dying
|
8.2
|
| |
Judaism: Rituals of death and dying in Israeli Jewish culture
|
2.2
|
| |
Latvia: The growth of palliative care for children in Latvia
|
11.3
|
LCP: Dutch experiences with the Liverpool Care Pathway
|
13.4
|
Learning difficulties, Caring for people with
|
12.6
|
Learning disabilities: Bereavement in people with learning disabilities
|
4.5
|
Learning disabilities: Going to the theatre to talk about cancer
|
12.3
|
Learning disabilities: Palliative care for people with learning disabilities
|
12.3
|
Learning disabilities: Reconnecting death and intellectual disability
|
12.1
|
Learning disabilities: Terminal care in an institution
|
11.4
|
Lebanon: The view from Lebanon
|
12.6
|
Leukaemia: The case study masterclass. Case 22. A patient with acute myeloid leukaemia
|
12.5
|
Leukaemia: The case study masterclass: Case 13. A man with no evidence of recurrent acute myeloid leukaemia
|
11.1
|
Liverpool Care Pathway for the dying patient, Adapting the
|
12.6
|
Liverpool Care Pathway: Adapting the Liverpool Care Pathway for intensive care units
|
16.3
|
Living wills: studying the Dutch experience
|
3.4
|
Lung cancer: The case study masterclass: Case 10. Presentation of lung cancer
|
10.4
|
Lung cancer: The case study masterclass: Case 3. Small cell lung cancer
|
9.3
|
Lymphoedema: Use of microsurgery in lymphoedema management
|
16.1
|
Lymphorrhoea in palliative care
|
4.2
|
| |
Malodour: The management of malodour
|
5.5
|
Medicalisation: Routinisation and medicalisation
|
6.6
|
Melanoma: The case study masterclass: Case 15. A man with metastatic malignant melanoma and nausea
|
11.3
|
Mental capacity assessment of terminally ill patients
|
8.6
|
Mental capacity: Decision-making and the law for patients who lack capacity
|
16.1
|
Mental health: A social work perspective on palliative care for people with mental health problems
|
13.1
|
Mental health: Borderline personality disorder: challenges in the palliative care setting
|
16.1
|
Mental heath: Palliative care for people with mental health problems
|
13.5
|
Mesothelioma and asbestos – from magic mineral to public health disaster
|
10.5
|
Mesothelioma, The case study masterclass: Case 23. Difficult pain in a patient with
|
12.6
|
Mesothelioma: The case study masterclass: Case 36. A complex patient with a thymoma and severe paraneoplastic cerebellar syndrome
|
15.1
|
Mesothelioma: The case study masterclass: Case 6. Mesothelioma
|
9.6
|
Midazolam infusions in palliative care, The use of
|
12.6
|
Mobile palliative care teams, Limitations and variations in
|
5.3
|
Morphine: Morphine metabolites: a review of their clinical effects
|
15.3
|
Motor neuron disease
|
8.1
|
Motor neurone disease: Palliative care for patients with MND/ALS
|
11.5
|
Motor neurone disease: The case study masterclass: Case 33. Managing an elderly, independent patient with motor neurone disease
|
14.4
|
Motor neurone disease: Tracheostomy ventilation in motor neurone disease
|
15.2
|
Multiculturalism: Catering for the needs of foreign patients
|
3.1
|
Multiculturalism: Cultural issues in palliative care
|
2.3
|
Multiculturalism: Symptom management in transcultural nursing
|
2.3
|
Music therapy: The role of music therapy in children’s hospices
|
14.3
|
Music therapy: Using music as a spiritual tool in palliative care
|
7.2
|
Myoclonus: Opioid-induced myoclonus
|
2.4
|
| |
Nausea and vomiting in advanced cancer
|
5.2
|
Nausea and vomiting: Safer anti-emetic prescribing for the palliative population
|
11.2
|
Nausea and vomiting: Use of atypical antipsychotic olanzapine as an anti-emetic
|
12.4
|
Nausea: Octreotide in terminal malignant obstruction of the gastrointestinal tract
|
1.1
|
NCHSPCS: Achievements and intentions – the work of the NCHSPCS
|
3.3
|
Netherlands: Developments in palliative care services in the Netherlands
|
11.1
|
Netherlands: Dutch GPs get 24-hour telephone advice on how to treat nausea and vomiting
|
15.6
|
Netherlands: NPTN: palliative care comes under the spotlight in the Netherlands
|
16.3
|
Netherlands: Palliative care for the terminally ill in the Netherlands: the unique role of nursing homes
|
6.5
|
New Zealand: The status of hospice and palliative care in New Zealand
|
7.5
|
NHS: Hospice and NHS partnership
|
11.6
|
NICE guidance: Improving palliative care
|
11.2
|
Nurse specialists: Redefining the role of the clinical nurse specialist
|
7.5
|
Nursing: Caring for the body at the end of life
|
12.5
|
Nursing: Choosing to nurse the dying
|
8.1
|
Nursing: Competency assessment in palliative
|
7.3
|
Nursing: The art of caring
|
8.5
|
Nutrition for terminally ill elderly patients
|
1.2
|
Nutrition: Artificial nutrition at the end of life: is it justified?
|
13.5
|
Nutrition: Is there still any pleasure in eating for palliative care patients?
|
11.2
|
Nutrition: Nutritional issues in advanced cancer
|
6.2
|
Nutrition: The nutritional aspects of palliative care
|
13.5
|
| |
Obituary: Homage to Vittorio Ventafridda
|
16.1
|
Occupational therapy in a hospice inpatient unit
|
11.5
|
Occupational therapy: Home assessment before discharge from a palliative care unit
|
1.2
|
Occupational therapy: The role of the occupational therapist in palliative care
|
6.5
|
Occupational therapy: The use of an occupational therapy programme within a palliative care setting
|
9.1
|
Opioid-induced constipation
|
15.6:Sponsoredsupplement
|
Opioid-induced constipation: Clinical practice recommendations for the management of constipation in palliative care: what do they mean for opioid-induced constipation?
|
16.1:Sponsoredsupplement
|
Opioid-induced constipation: Targeted management of opioid-induced constipation: the role of the novel, peripherally acting, mu-opioid receptor antagonist methylnaltrexone bromide
|
15.6:Sponsoredsupplement
|
Opioids: An overview of opioids in palliative care: part 2
|
14.1
|
Opioids: Opioid use in the last days of life: what is good practice?
|
16.3
|
Opioids: The case study masterclass: Case 37. A patient with severe opioid-induced pain
|
15.2
|
Opioids: The case study masterclass: Case 42 answers. An elderly patient with opioid-induced constipation
|
16.2
|
Opioids: The case study masterclass: Case 42. An elderly patient with opioid-induced constipation
|
16.1
|
Oral candidosis: how to treat a common problem
|
10.2
|
Oral candidosis: The case study masterclass: Case 44. A recurrent case of pseudomembranous candidosis
|
16.3
|
Organ donation in palliative care
|
5.1
|
Organisation: Building a specialist palliative care library
|
9.2
|
Out-of-hours care: Out-of-hours palliative care – bridging the gap
|
7.1
|
Outcomes and visions
|
7.4
|
Outcomes: Assessing the outcome of palliative care
|
6.6
|
Oxygen therapy: Using oxygen therapy in the palliative care setting
|
14.3
|
| |
Paediatrics: 1st Annual European Course on Palliative Care for Children
|
7.3
|
Paediatrics: A model for reflection in children’s palliative care
|
13.1
|
Paediatrics: Caring for terminally ill children in the home setting
|
10.5
|
Paediatrics: Childhood deaths in Italy
|
15.2
|
Paediatrics: Children’s needs: key figures from the Veneto region, Italy
|
15.6
|
Paediatrics: Determining the need for terminal care for children
|
9.2
|
Paediatrics: Helen House: a model of children’s hospice care
|
2.1
|
Paediatrics: Paediatric palliative care
|
13.1
|
Paediatrics: Paediatric palliative care – a personal perspective
|
5.3
|
Paediatrics: Palliative care for children in Poland
|
6.4
|
Paediatrics: Palliative care in Poland – the Warsaw Hospice for Children
|
13.1
|
Paediatrics: Practices in paediatric palliative care in Lebanon
|
15.4
|
Paediatrics: The Belarus Children’s Hospice
|
6.1
|
Paediatrics: The case study masterclass: Case 25. Palliative care of a paediatric patient with relapsed neuroblastoma
|
13.2
|
Paediatrics: The development of children's hospices in the UK
|
8.1
|
Paediatrics: The development of paediatric palliative care in Warsaw, Poland
|
10.3
|
Paediatrics: The evolution of palliative care for children in Greece
|
8.1
|
Paediatrics: The Mercer model of paediatric palliative care
|
12.1
|
Paediatrics: The view from a bridge
|
9.2
|
Pain and the use of opioids in treating elderly patients
|
15.1
|
Pain as an ethical and religious problem
|
4.2
|
Pain control: An audit of pain control in patients with malignant disease managed with oral opioids analgesics in six practices in England and Scotland
|
10.2:Sponsoredsupplement
|
Pain: Another pain management model for developing countries
|
13.3
|
Pain: Assessment of neuropathic pain in palliative medicine
|
14.4
|
Pain: Cancer pain management in Colombia
|
9.3
|
Pain: Cancer pain syndromes
|
7.6
|
Pain: Could shoulder pain be supra-scapular nerve entrapment?
|
13.3
|
Pain: Critical appraisal of invasive therapies used to treat chronic pain and cancer pain
|
7.4
|
Pain: Intractable pain in the terminally ill
|
4.2
|
Pain: Neuropathic pain in young children with cancer
|
3.3
|
Pain: Pain and suffering as existential questions in palliative care
|
1.1
|
Pain: Pain control in peripheral arterial occlusive disease
|
14.5
|
Pain: Patient transport: another source of pain
|
12.3
|
Pain: Social representations of pain
|
5.3
|
Pain: Terminal cancer pain
|
8.2
|
Pain: The case study masterclass: Case 12. Pain from head and neck cancer that was difficult for everyone
|
10.6
|
Pain: The case study masterclass: Case 26. Managing a patient with complex pain and adenocarcinoma
|
13.3
|
Pain: The DOLOPLUS® 2 scale – evaluating pain in the elderly
|
8.5
|
Pain: The pitfalls of visual analogue scales in palliative medicine
|
14.3
|
Pain: Treating pain and caring for children at the end of life
|
11.5
|
Pain: What is all this pain good for?
|
10.4
|
Palliative care services: Evaluating a palliative care consultation service
|
11.2
|
Palliative care services: Palliative care patients: what services do they really want?
|
15.6
|
Palliative care unit: The attending doctor and the palliative care unit
|
11.4
|
Palliative care: A movement full of promise
|
13.2
|
Palliative care: Dying for palliative care
|
4.3
|
Palliative care: How vignettes can aid social research in palliative care
|
14.6
|
Palliative care: Is specialist palliative care social work being neglected?
|
15.1
|
Palliative care: Syringe driver site reactions: a review of the literature
|
15.3
|
Palliative care: The construction of palliative care: experience and challenges
|
13.2
|
Palliative sedation: Can palliative sedation be a solution when a patient requests active euthanasia?
|
15.6
|
Paraneoplastic syndrome: Paraneoplastic syndromes in advanced malignancy
|
3.2
|
Paratonia: Discomfort and pain associated with paratonia
|
3.2
|
Paternalism: Can medical paternalism ever be justified?
|
8.4
|
Paternalism: Can patients’ relatives justify colluding with healthcare staff?
|
7.6
|
Patient choice: Managing expectations
|
10.5
|
Patient choice: The case study masterclass: Case 40 answers. A lung cancer patient with caring responsibilities making hospitalisation difficult
|
15.6
|
Patient choice: The case study masterclass: Case 40. A lung cancer patient with caring responsibilities making hospitalisation difficult
|
15.5
|
Patient choice: The dilemma of therapy
|
9.5
|
Patient choice: The recognition and respect of patient needs at the end of life
|
11.6
|
Patient histories: Recording lives: the benefits of an oral history service
|
16.3
|
Patient information: Designing and producing a patient leaflet on morphine
|
3.3
|
Patient records: A multidisciplinary approach to terminal care
|
9.1
|
Patient records: Summary Care Record – the Bury experience
|
16.3
|
Patient-centred care: Paradoxes in palliative care
|
7.3
|
Patient-centred care: User involvement in palliative care services
|
8.6
|
Patient-held records: ‘patient-led’ or ‘professionally led’?
|
9.5
|
Percutaneous nephrostomy in patients with cervical cancer
|
12.4
|
Physiotherapy: The contribution of physiotherapy to palliative care
|
7.3
|
Plastic surgery: Palliative plastic surgery
|
7.3
|
Pleural effusions: Malignant pleural effusions
|
6.1
|
Poland: A holistic approach to palliative care in Poland
|
14.2
|
Poland: The development of palliative care in Poznan, Poland
|
10.1
|
Pregnancy: Care for the dying mother-to-be
|
9.6
|
Prescribing: Nurse prescribing in the UK
|
1.1
|
Prescription: Spanish rules governing prescription of opioids
|
5.1
|
Prisoners: Providing palliative care for prisoners
|
13.6
|
Prisoners: The case study masterclass: Case 17. A prisoner with a history of drug abuse
|
11.5
|
Prisoners: The specialist palliative care of prisoners
|
5.3
|
Problem-solving: Balancing in palliative care
|
11.4
|
Prognosis: Prognostic factors in terminal cancer patients
|
1.3
|
Prognostication: How long have I got? – prognostication and palliative care
|
6.6
|
Prokinetic drugs: The use of prokinetic drugs in palliative care
|
2.4
|
Prostatic cancer: The case study masterclass: Case 9. Rapidly progressing prostatic cancer
|
10.3
|
Pruritus: Managing severe pruritus in cancer patients
|
14.3
|
Pruritus: The management of pruritus in palliative care patients
|
7.1
|
Pseudomyxoma peritonei: Caring for patients with pseudomyxoma peritonei
|
11.4
|
Psychedelic drugs: Can psychedelic drugs play a role in palliative care?
|
15.5
|
Psychiatric institutions: Palliative care in psychiatric institutions
|
9.4
|
Psychology: A tailor-made psychological approach to palliative care
|
14.4
|
Psychology: Are patients’ psychological needs being met?
|
14.4
|
Psychosocial oncology: Psychosocial nursing – a new discipline in cancer care
|
3.1
|
Public health policy: Palliative care and its impact on public health policy
|
11.5
|
| |
Quality of life in terminally ill cancer patients
|
9.6
|
Quality of life: Can we talk of quality of life just before death?
|
7.6
|
Quality of life: Measuring quality of life in patients with advanced cancer
|
11.3
|
Quality of life: Quality of life for all
|
5.1
|
Quality of life: Quality of life measures: practical considerations
|
14.2
|
Quality-of-life: The use of quality-of-life instruments in palliative care
|
9.2
|
| |
Radioisotopes: Using radioisotopes for bone metastases
|
1.2
|
Radiotherapy fractionation in palliative care
|
6.4
|
Radiotherapy: The case study masterclass: Case 38. Severe tenesmus and anal pain as a result of radiotherapy
|
15.3
|
Radiotherapy: The role of radiotherapy and chemotherapy in NSCLC
|
11.5
|
Rehabilitation in an inpatient palliative unit
|
1.4
|
Religion: A question of faith for the Hindu patient
|
7.3
|
Religion: Judaism and palliative care
|
6.5
|
Religion: Muslim beliefs regarding death and bereavement
|
10.1
|
Renal cell carcinoma: The case study masterclass: Case 19. A complex patient with metastatic renal cell carcinoma
|
12.2
|
Renal failure in palliative care patients
|
15.2
|
Renal failure: Pain management in patients with renal impairment
|
15.5
|
Renal failure: Symptom control for patients dying with advanced CKD
|
15.6
|
Renal failure: The case study masterclass: Case 4. Chronic renal failure
|
9.4
|
Renal: Decision-making for renal patients at the end of life
|
14.5
|
Repatriation: Returning foreign patients to their home country
|
3.4
|
Research: A platform for ideas
|
7.2
|
Research: An international collaboration for family carer research
|
13.4
|
Research: Conducting research in the palliative care population
|
11.1
|
Research: Ensuring the wellbeing of participants and researchers i
|
13.3
|
Research: Minimising gate-keeping in palliative care research
|
12.4
|
Research: New paradigm research in palliative care
|
5.4
|
Research: Reflections on evaluation research in palliative care
|
13.3
|
Research: Research training and palliative medicine
|
7.3
|
Research: The EAPC Research Network meets in Trondheim
|
15.3
|
Research: The language of diversity: controversies relevant to palliative care research
|
13.1
|
Research: The strengths and weaknesses of telephone interviews
|
16.2
|
Research: User involvement in cancer care research
|
13.6
|
Research: Using the concept of speed dating in research into illness
|
15.1
|
Resilience: Resilience in palliative care
|
13.1
|
Respite: A neurological respite programme in a specialist palliative care setting
|
12.5
|
Respite: An audit of respite provision in a palliative care setting
|
14.2
|
Restraints: Using restraints – definition, understanding and challenges
|
15.2
|
Resuscitation in the media: does it matter?
|
10.5
|
Resuscitation: CPR for people who are terminally ill
|
4.4
|
Resuscitation: Developing guidelines for resuscitation in terminal care
|
9.2
|
Resuscitation: knowing whether it is right or wrong
|
15.4
|
Resuscitation: Medically futile resuscitation: can it ever be justified?
|
12.5
|
Romania: An update on paediatric palliative care in Romania
|
14.6
|
Romania: Developing a paediatric hospice programme in Romania
|
11.2
|
Romania: The development of palliative care in Brasov, Romania
|
9.5
|
Russia: The development of palliative care in St Petersburg, Russia
|
10.2
|
Russia: The hospice movement in Russia
|
3.1
|
| |
Saudi Arabia: Palliative care in the Kingdom of Saudi Arabia
|
8.5
|
Saunders, Cicely: A voice for the voiceless
|
7.3
|
Sedation and terminal care
|
8.3
|
Sedation: Reflections on the use of sedation in terminal care
|
9.6
|
Serotonin syndrome: a hidden danger in palliative care
|
12.3
|
Service provision: Caring for young adults with rare neurological conditions
|